The United States is turning its back on what could be the greatest medical advance in a generation — vaccines made with messenger RNA, or mRNA, technology. The U.S. Department of Health and Human ...
By halting funding for mRNA research, the government is endangering America’s health and leadership in biomedical innovation.
Multilateral initiatives are needed to signal confidence and fill funding gaps in mRNA research, writes Jennifer B Nuzzo Recently the US secretary of health and human services Robert F Kennedy Jr ...
The most widely used COVID-19 vaccines may offer a surprise benefit for some cancer patients by boosting their immune systems ...
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES // VANCOUVER, BC, Oct. 30, 2025 /PRNewswire/ -- BioVaxys Technology ...
Under the bright lights of Durban’s convention centre, amid applause from scientists and policymakers gathered for the 4th ...
"What the recent CDC recommendations suggest is that people with more domain-specific knowledge about immunization are needed ...
The Needle-Free Injection System Market represents a groundbreaking advancement in medical technology, offering an innovative ...
BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) ("BioVaxys" or the "Company") announces an increase to its non-brokered ...
It’s notoriously tough to land a political blow on Donald Trump, but California congressman Ro Khanna is one of the few ...
For more than half a century, Johns Hopkins has been a leader in converting federal support into tangible benefits for the ...
President Trump leafed through the MAHA report moments before its public release, scanning the document that laid the blame ...